An Advanced Practice Practitioner–Based Program to Reduce 30‐ and 90‐Day Readmissions After Liver Transplantation

Nadim Mahmud, Samantha Halpern, Rebecca Farrell, Kate Ventura, Arwin Thomasson, Heidi Lewis, Kim M. Olthoff, Matthew H. Levine, Susanna Nazarian, Vandana Khungar – 4 April 2019 – Hospital readmissions after liver transplantation (LT) are common and associated with increased morbidity and cost. High readmission rates at our center motivated a change in practice with adoption of a nurse practitioner (NP)–based posttransplant care program.

A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision‐Cut Liver Slices

Hannah L. Paish, Lee H. Reed, Helen Brown, Mark C. Bryan, Olivier Govaere, Jack Leslie, Ben S. Barksby, Marina Garcia Macia, Abigail Watson, Xin Xu, Marco Y.W. Zaki, Laura Greaves, Julia Whitehall, Jeremy French, Steven A. White, Derek M. Manas, Stuart M. Robinson, Gabriele Spoletini, Clive Griffiths, Derek A. Mann, Lee A. Borthwick, Michael J.

Reply

Silvia Nardelli, Stefania Gioia, Lorenzo Ridola, Alessio Farcomeni, Manuela Merli, Oliviero Riggio – 4 April 2019

The Contents of Herbal and Dietary Supplements Implicated in Liver Injury in the United States Are Frequently Mislabeled

Victor Navarro, Bharathi Avula, Ikhlas Khan, Manisha Verma, Leonard Seeff, Jose Serrano, Andrew Stolz, Robert Fontana, Jawad Ahmad – 3 April 2019 – The U.S. Drug Induced Liver Injury Network assayed the contents of herbal and dietary supplements collected from patients enrolled into its prospective study. The aim was to determine the accuracy of product labels, and to identify known hepatotoxins. Using high‐performance liquid chromatography coupled with mass spectrometry to assay 272 product, 51% were found to be mislabeled; that is, to have chemical contents that did not match the label.

Serum Liver‐Type Fatty Acid–Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma

Akiko Eguchi, Hiroshi Hasegawa, Motoh Iwasa, Yasuyuki Tamai, Keiichi Ohata, Tsuyoshi Oikawa, Takeshi Sugaya, Yoshiyuki Takei – 2 April 2019 – Liver‐type fatty acid–binding protein (L‐FABP) is a key regulator of fatty acid metabolism, but serum L‐FABP levels are not well investigated in chronic liver diseases. We aimed to elucidate the prognostic ability of serum L‐FABP in human chronic liver diseases and compare it with the albumin‐bilirubin (ALBI) score.

Characteristics of Impaired Dendritic Cell Function in Patients With Hepatitis B Virus Infection

Atsushi Yonejima, Eishiro Mizukoshi, Toshikatsu Tamai, Hidetoshi Nakagawa, Masaaki Kitahara, Tatsuya Yamashita, Kuniaki Arai, Takeshi Terashima, Noriho Iida, Kazumi Fushimi, Hikari Okada, Taro Yamashita, Yoshio Sakai, Masao Honda, Shuichi Kaneko – 2 April 2019 – Dendritic cells (DCs) are antigen‐presenting cells with a central role in host immune response. This study analyzed gene expression and DC function in hepatitis B virus (HBV) patients, functions impaired because of HBV, and identified the genes related to these functions.

Subscribe to